|
1
|
Kleiman DA, Buitrago D, Crowley MJ,
Beninato T, Veach AJ, Zanzonico PB, Jin M, Fahey TJ III and
Zarnegar R: Thyroid stimulating hormone increases iodine uptake by
thyroid cancer cells during BRAF silencing. J Surg Res. 182:85–93.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
HombachKlonisch S, Natarajan S,
Thanasupawat T, Medapati M, Pathak A, Ghavami S and Klonisch T:
Mechanisms of therapeutic resistance in cancer (stem) cells with
emphasis on thyroid cancer cells. Front Endocrinol (Lausanne).
25:5–37. 2014.
|
|
3
|
Pellegriti G, Frasca F, Regalbuto C,
Squatrito S and Vigneri R: Worldwide increasing incidence of
thyroid cancer: Update on epidemiology and risk factors. J Cancer
Epidemiol. 2013:9652122013.PubMed/NCBI
|
|
4
|
Stjepanovic N and Capdevila J: Multikinase
inhibitors in the treatment of thyroid cancer: Specific role of
lenvatinib. Biologics. 8:129–139. 2014.PubMed/NCBI
|
|
5
|
Massimino M, Vigneri P, Fallica M, Fidilio
A, Aloisi A, Frasca F and Manzella L: IRF5 promotes the
proliferation of human thyroid cancer cells. Mol Cancer. 16:11–21.
2012.
|
|
6
|
Fagin JA: Perspective: Lessons learned
from molecular genetic studies of thyroid cancer-insights into
pathogenesis and tumor-specific therapeutic targets. Endocrinology.
143:2025–2028. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hancock RE and Chapple DS: Peptide
antibiotics. Antimicrob Agents Chemother. 43:1317–1323.
1999.PubMed/NCBI
|
|
8
|
Hancock RE and Sahl HG: Antimicrobial and
host-defense peptides as new anti-infective therapeutic strategies.
Nat Biotechnol. 24:1551–1557. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mulder KC, Lima LA, Miranda VJ, Dias SC
and Franco OL: Current scenario of peptide-based drugs: The key
roles of cationic antitumor and antiviral peptides. Front
Microbiol. 4:3212013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mader JS and Hoskin DW: Cationic
antimicrobial peptides as novel cytotoxic agents for cancer
treatment. Expert Opin Investig Drugs. 15:933–946. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Camilio KA, Berge G, Ravuri CS, Rekdal O
and Sveinbjørnsson B: Complete regression and systemic protective
immune responses obtained in B16 melanomas after treatment with
LTX-315. Cancer Immunol Immunother. 63:601–613. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schweizer F: Cationic amphiphilic peptides
with cancer-selective toxicity. Eur J Pharmacol. 625:190–194. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Riedl S, Zweytick D and Lohner K:
Membrane-active host defense peptides-challenges and perspectives
for the development of novel anticancer drugs. Chem Phys Lipids.
164:766–781. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu S, Yang H, Wan L, Cheng J and Lu X:
Penetratin-mediated delivery enhances the antitumor activity of the
cationic antimicrobial peptide magainin II. Cancer Biother
Radiopharm. 28:289–297. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lynn MA, Kindrachuk J, Marr AK, Jenssen H,
Panté N, Elliott MR, Napper S, Hancock RE and McMaster WR: Effect
of BMAP-28 antimicrobial peptides on Leishmania major
promastigote and amastigote growth: Role of leishmanolysin in
Parasite Survival. PLoS Negl Trop Dis. 5:e11412011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Benincasa M, Skerlavaj B, Gennaro R,
Pellegrini A and Zanetti M: In vitro and in vivo
antimicrobial activity of two alpha-helical cathelicidin peptides
and of their synthetic analogs. Peptides. 24:1723–1731. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Giacometti A, Cirioni O, Ghiselli R,
Bergnach C, Orlando F, D'Amato G, Mocchegiani F, Silvestri C, Del
Prete MS, Skerlavaj B, et al: The antimicrobial peptide BMAP-28
reduces lethality in mouse models of staphylococcal sepsis. Crit
Care Med. 32:2485–2490. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ahmad A, Asthana N, Azmi S, Srivastava RM,
Pandey BK, Yadav V and Ghosh JK: Structure-function study of
cathelicidin-derived bovine antimicrobial peptide BMAP-28: Design
of its cell-selective analogs by amino acid substitutions in the
heptad repeat sequences. Biochim Biophys Acta. 1788:2411–2420.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Starenki D and Park JI:
Mitochondria-targeted nitroxide, Mito-CP, suppresses medullary
thyroid carcinoma cell survival in vitro and in vivo.
J Clin Endocrinol Metab. 98:1529–1540. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang H, Ke M, Tian Y, Wang J, Li B, Wang
Y, Dou J and Zhou C: BF-30 selectively inhibits melanoma cell
proliferation via cytoplasmic membrane permeabilization and
DNA-binding in vitro and in B16F10-bearing mice. Eur J
Pharmacol. 707:1–10. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tian Y, Wang H, Li B, Ke M, Wang J, Dou J
and Zhou C: The cathelicidin-BF Lys16 mutant Cbf-K16 selectively
inhibits non-small cell lung cancer proliferation in vitro.
Oncol Rep. 30:2502–2510. 2013.PubMed/NCBI
|
|
22
|
Cheng YX, Liu R, Wang Q, Li BS, Xu XX, Hu
M, Chen L, Fu Q, Pu DM and Hong L: Regular-induced apoptosis of
cervical cancer cell line siha via cytochrome c release and
caspase-3 and caspase-9 activation. Chin J Integr Med. 18:359–365.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lu J, Yao YY, Dai QM, Ma GS, Zhang SF, Cao
L, Ren LQ and Liu NF: Erythropoietin attenuates cardiac dysfunction
by increasing myocardial angiogenesis and inhibiting interstitial
fibrosis in diabetic rats. Cardiovasc Diabetol. 11:1052012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Han YY, Liu HY, Han DJ, Zong XC, Zhang SQ
and Chen YQ: Role of glycosylation in the anticancer activity of
antibacterial peptides against breast cancer cells. Biochem
Pharmacol. 86:1254–1262. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tseng TH, Shen CH, Huang WS, Chen CN,
Liang WH, Lin TH and Kuo HC: Activation of
neutral-sphingomyelinase, MAPKs and p75 NTR-mediating caffeic acid
phenethyl ester-induced apoptosis in C6 glioma cells. J Biomed Sci.
21:612014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Floyd DH, Zhang Y, Dey BK, Kefas B, Breit
H, Marks K, Dutta A, HeroldMende C, Synowitz M, Glass R, et al:
Novel anti-apoptotic microRNAs 582-5p and 363 promote human
glioblastoma stem cell survival via direct inhibition of
caspase 3, caspase 9 and Bim. PLoS One. 9:e962392014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wyllie AH: ‘Where, O death, is thy sting?’
A brief review of apoptosis biology. Mol Neurobiol. 42:4–9. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nagase H and Woessner JF Jr: Matrix
metalloproteinases. J Biol Chem. 274:21491–21494. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim YS, Kim SH, Kang JG and Ko JH:
Expression level and glycan dynamics determine the net effects of
TIMP-1 on cancer progression. BMB Rep. 45:623–628. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim HR, Kim JM, Kim MS, Hwang JK, Park YJ,
Yang SH, Kim HJ, Ryu DG, Lee DS, Oh H, et al: Saussurea
lappa extract suppresses TPA-induced cell invasion via
inhibition of NF-κB-dependent MMP-9 expression in MCF-7 breast
cancer cells. BMC Complement Altern Med. 14:1702014. View Article : Google Scholar : PubMed/NCBI
|
